The shares of Bristol-Myers Squibb Company (NYSE:BMY) and Marathon Petroleum Corporation (NYSE:MPC) were among the active stocks of the last trading sessions. Bristol-Myers Squibb Company (NYSE:BMY) soared to 0.79% closing at the price of $62.9 whereas the shares of Marathon Petroleum Corporation (NYSE:MPC) declined -0.77% with the decrease of -0.65 points closing at the price of $83.86. Bristol-Myers Squibb Company has currently increase 2.76% in its stock over the period of 6-months while its rival Marathon Petroleum Corporation added 13.79% in the previous 6-months.
Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.
Returns and Profitability
Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.
The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Bristol-Myers Squibb Company (NYSE:BMY) is 20.2% while the ROI of Marathon Petroleum Corporation (NYSE:MPC) is 10.9%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, BMY’s EBITDA Margin is 17.43 whereas MPC’s is 8.35.
Both the profitability ratios suggest that Bristol-Myers Squibb Company (NYSE:BMY) is more suitable investment in terms of profitability and return.
EPS & Surprise Factor
Bristol-Myers Squibb Company (NYSE:BMY) reported $1.01/share EPS for the previous quarter where analysts were predicting an EPS to be $0.87/share Thus beating the analyst Estimates with a Surprise Factor of 16.1 Percent. While, Marathon Petroleum Corporation (NYSE:MPC) reported EPS of $2.27/share in the last quarter. The analysts projected EPS of $2.03/share depicting a Surprise of 11.8 Percent.
Taking a look at Earnings per Share, Bristol-Myers Squibb Company tends to be beating the analyst estimates more than Marathon Petroleum Corporation. so BMY is more profitable than MPC.
Technical Analysis of Bristol-Myers Squibb Company & Marathon Petroleum Corporation
Moving average convergence divergence (MACD) shows that Bristol-Myers Squibb Company (NYSE:BMY) is on a PRICE RELATIVITY trend While Marathon Petroleum Corporation (NYSE:MPC) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Bristol-Myers Squibb Company was in BULLISH territory and Marathon Petroleum Corporation was in BULLISH territory.
BMY’s current statistics gauge that the stock candle is BULLISH with LOW volatility. While MPC’s candle is BEARISH with MEDIUM.
EPS Growth Rate: BMY’s 10.97% versus MPC’s 57.94%
Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Bristol-Myers Squibb Company (NYSE:BMY) is predicted at 10.97% while Marathon Petroleum Corporation (NYSE:MPC) stands at 57.94%. These numbers suggest that MPC is more suitable investment in terms of EPS growth rate.
Financial Risk and Liquidity Concerns
The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of BMY stands at 1.4 while MPC is at 1.6 whereas the debt ratio of the prior is 0.6 while the debt ratio of the later is 1.15.
The values of the both ratios suggest that MPC is more suitable investment when the liquidity and risk is the main concern.
While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.4 for BMY and 1.8 for MPC which means BMY has Hold rating whereas MPC has Buy rating.
Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for BMY is $60.5 which is -3.97% of its current price while MPC has price target of 103.08 which is 18.65% of its current price.
Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.
BMY currently has price to earning P/E ratio of 31.25 whereas MPC has 16.22 while the forward P/E ratio for the prior stands at 16.11 and for the later it depicts the value of 10.91.
The price to Book P/B for BMY is 8.34, Price to Sale is at 4.75 and for MPC these ratios stand at 2.57 and 0.47.